<DOC>
	<DOCNO>NCT00197288</DOCNO>
	<brief_summary>The purpose study compare two licensed influenza vaccine ( Fluzone Fluarix ) term immune response elicit safety/ symptom may occur six month vaccination .</brief_summary>
	<brief_title>Study Comparing Immune Response Fluarix Fluzone Influenza Vaccines</brief_title>
	<detailed_description>- Experimental design : multi-center , randomize ( 1:1 ) , observer-blind , active-controlled study 2 parallel group approximately : - Study vaccine : full dose Fluarix IM administration . - Control vaccine : full dose Fluzone IM administration . - Two scheduled visit per subject day 0 ( visit 1 ) 21 ( visit 2 ) blood sample collect visit evaluate immune response . There final contact subject 6 month vaccination safety follow study conclusion . - Vaccination schedule : one IM injection day 0 . - Type study : Self contain .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>All adult 18 year old . Subjects investigator believe comply requirement protocol ( e.g. , return followup visit completion diary card ) enrol study . Written inform consent obtain subject . If subject female , must nonchildbearing potential , i.e . either surgically sterilize one year postmenopausal ; , childbearing potential , must abstinent use adequate contraceptive precaution . Use investigational nonregistered product ( drug vaccine ) within 30 day precede administration study vaccine , plan use study period . Has receive license vaccine within 2 week ( inactivated vaccine ) 4 week ( live vaccine ) prior enrollment study . History hypersensitivity previous dose influenza vaccine . History allergy reaction likely exacerbate component vaccine ( ) include egg , chicken protein , gelatine , formaldehyde , gentamicin sulphate , thimerosal sodium deoxycholate . Acute disease time enrollment . ( Acute disease define presence moderate severe illness without fever . All vaccine administer person minor illness diarrhea , mild upper respiratory infection without lowgrade febrile illness , i.e . Oral temperature &lt; 37.5°C ( 99.5°F ) / Axillary temperature &lt; 37.5°C ( 99.5°F ) ) . History Guillain Barré syndrome within 6 week prior receipt inactivated influenza virus vaccine . Pregnancy lactate female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Prophylaxis : Influenza virus infection</keyword>
</DOC>